EMIS is the world's leading provider of information on emerging market companies and industry sectors. Our database contains information on over 4.7 million listed and private companies in over 125 countries. We also produce hugely detailed analysis on the most important business sectors in key markets.
EMIS Insights provide comprehensive reports on individual business sectors in the world's largest emerging markets. Each report examines the state-of-play for an individual sector in a single country. Find out what's next in the markets that matter to you.
EMIS provides detailed reports for companies in emerging markets. Our company profiles include everything needed to make an assessment of a business including main activities, key contacts, financial performance, peer businesses and more.
The gross value added (GVA) of the Czech pharmaceutical sector amounted to CZK 19.4bn in 2017, increasing by a real 11.1% y/y. The sector accounted for 0.4% of the GDP that year. The pharmaceutical sector employed 9,855 workers in 2017, accounting ...READ MORE
Although the global pharma & healthcare sector is dominated by large multinational companies, mainly from the developed countries, Latin America has been quickly catching up in building a domestic pharmaceutical production base and expanding the ...READ MORE
If you need regular and ongoing access to company information, you should consider a subscription to the full EMIS service.
EMIS company profiles are part of a larger information service where that combines company, industry and country data and analysis for over 125 emerging markets on a unique information platform.